Results 171 to 180 of about 83,125 (304)

Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Zhang H, Zhao Y, Chen Y, Feng Y, Shen B, Dong S, Zhu J, Jiang X, Li D, Chen Y, Han F, Zhang L.   +11 more
europepmc   +1 more source

Non-visual hallucinations in Parkinson's disease: a systematic review. [PDF]

J Neurol, 2023
Toh WL, Yolland C, Gurvich C, Barnes J, Rossell SL.   +4 more
europepmc   +1 more source

The Supreme Court of Canada interprets the fitness to stand trial test in R v. Bharwani

Journal of Forensic Sciences, EarlyView.
Abstract At the core of the common law, rooted in fairness, is the principle that an accused must be “fit” or “competent” to answer charges pursued by the state. Fitness rules vary considerably across jurisdictions but generally share the requirement that the accused be able to actively participate in the conduct of their defense.
Dennis Curry, Jason Quinn
wiley   +1 more source

Modelling phenomenological differences in aetiologically distinct visual hallucinations using deep neural networks. [PDF]

Front Hum Neurosci, 2023
Suzuki K, Seth AK, Schwartzman DJ.
europepmc   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Stroboscopically induced visual hallucinations: historical, phenomenological, and neurobiological perspectives. [PDF]

Neurosci Conscious
Hewitt T, Amaya I, Beauté R, Seth AK, Schmidt TT, Schwartzman DJ.   +5 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Virtual reality for visions (VRV): a proof-of-concept study examining the development of a new treatment for distressing visual hallucinations in people with psychosis. [PDF]

BMJ Open
Dudley R, Sargeant S, Gibbs C, Prentice L, McCartney L, Aynsworth C, Maskey M, Skeggs A.   +7 more
europepmc   +1 more source

Pulvinar quantitative susceptibility mapping predicts visual hallucinations post-deep brain stimulation in Parkinson's disease. [PDF]

Brain Behav, 2023
Matsuura K, Ii Y, Maeda M, Tabei KI, Satoh M, Umino M, Kajikawa H, Araki T, Nakamura N, Matsuyama H, Shindo A, Tomimoto H.   +11 more
europepmc   +1 more source